Allergic Rhinitis and Its Impact on Work Productivity in Primary Care Practice and a Comparison with Other Common Diseases: The Cross-sectional Study to Evaluate Work Productivity in Allergic Rhinitis Compared with Other Common Diseases (CAPRI) Study

Abstract

AR impairs work productivity in a greater magnitude than hypertension and DM type II.

Estimate of the total costs of allergic rhinitis in specialized care based on real‐world data: the FERIN Study

“…Loss of productivity arising from AR is a key element of the socioeconomic burden of the disease. Results for presenteeism are homogeneous, showing a 25–30% reduction in work productivity during symptomatic periods .…”

“…Often considered a trivial disease, AR causes major subjective discomfort , significant sleep impairment , and considerably reduced workplace productivity and school performance . These characteristics and the high prevalence of AR (21.5% in Spain) highlight the socioeconomic burden of the disease.…”

Ear Acupressure for Perennial Allergic Rhinitis: A Multicenter Randomized Controlled Trial

“…6 Although PAR is not a life-threatening disease, it has a significant impact on patients' quality of life (QoL) and leads to a substantial health and economic burden. 2,[7][8][9][10] In addition, PAR is considered a risk factor for asthma, sinusitis, and other comorbidities. 2,6 The current management of PAR includes pharmacotherapy and allergen-specific immunotherapy.…”

Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia

“…AR results in considerable healthcare costs [1] and, if untreated, may have considerable economic and QoL implications [8-10]. The impact of AR on productivity is higher than that of asthma, diabetes, or heart disease [9, 10]. …”

“…The symptoms of AR and allergic rhinoconjunctivitis in Russian patients are found to impair health-related QoL to the same extent as patients in westernized countries, by adversely impacting sleep, daily activities, physical and mental status, and social functioning [7]. AR results in considerable healthcare costs [1] and, if untreated, may have considerable economic and QoL implications [8-10]. The impact of AR on productivity is higher than that of asthma, diabetes, or heart disease [9, 10].…”